4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-057093
President and CEO sold 25,550 shares at $5.00 ($127,750)
- President and CEO acquired 25,550 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Doerfler Douglas · President and CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-29 | Exercise or conversion : show line 1 in the form | +5,350 | $0.04 | $214 | 338,547 | D |
| 2023-11-29 | Sale : show line 2 in the form | −5,350 | $5.00 | $26,750 | 333,197 | D |
| 2023-12-01 | Exercise or conversion : show line 3 in the form | +20,200 | $0.04 | $808 | 353,397 | D |
| 2023-12-01 | Sale : show line 4 in the form | −20,200 | $5.00 | $101,000 | 333,197 | D |
| Open-market sales · 25,550 sh · avg $5.00 · $127,750 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-29 | Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) | −5,350 | 229,730 | D |
| 2023-12-01 | Exercise or conversion : show line 6 in the form Employee Stock Option (right to buy) | −20,200 | 209,530 | D |
Loading xslF345X05/doc4.xml…